Enovix Co. (NASDAQ:ENVX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $27.43.
ENVX has been the subject of a number of recent research reports. JPMorgan Chase & Co. cut their price objective on shares of Enovix from $18.00 to $12.00 and set an “overweight” rating for the company in a report on Friday. Canaccord Genuity Group reissued a “buy” rating and set a $17.00 price target on shares of Enovix in a research report on Wednesday, February 21st. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $30.00 price objective on shares of Enovix in a research note on Thursday.
Get Our Latest Stock Analysis on Enovix
Insider Buying and Selling at Enovix
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in Enovix by 4.1% during the 4th quarter. Vanguard Group Inc. now owns 12,928,993 shares of the company’s stock worth $161,871,000 after purchasing an additional 513,508 shares in the last quarter. Electron Capital Partners LLC lifted its stake in shares of Enovix by 20.0% in the 4th quarter. Electron Capital Partners LLC now owns 3,239,296 shares of the company’s stock valued at $40,556,000 after acquiring an additional 540,399 shares during the last quarter. Handelsbanken Fonder AB lifted its stake in shares of Enovix by 0.4% in the 3rd quarter. Handelsbanken Fonder AB now owns 2,622,620 shares of the company’s stock valued at $32,914,000 after acquiring an additional 9,800 shares during the last quarter. Masters Capital Management LLC boosted its holdings in shares of Enovix by 18.2% during the 4th quarter. Masters Capital Management LLC now owns 1,300,000 shares of the company’s stock valued at $16,276,000 after acquiring an additional 200,000 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Enovix by 5.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,089,959 shares of the company’s stock worth $13,646,000 after acquiring an additional 55,157 shares during the last quarter. Institutional investors own 50.92% of the company’s stock.
Enovix Price Performance
Enovix stock opened at $6.46 on Friday. The company has a market capitalization of $1.09 billion, a price-to-earnings ratio of -4.22 and a beta of 1.62. The stock’s 50 day moving average is $8.18 and its 200-day moving average is $10.10. The company has a current ratio of 5.30, a quick ratio of 5.15 and a debt-to-equity ratio of 0.65. Enovix has a 12 month low of $5.70 and a 12 month high of $23.90.
Enovix (NASDAQ:ENVX – Get Free Report) last posted its quarterly earnings data on Tuesday, February 20th. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.01). The firm had revenue of $7.38 million for the quarter, compared to the consensus estimate of $3.37 million. Enovix had a negative return on equity of 77.74% and a negative net margin of 2,800.51%. Equities research analysts expect that Enovix will post -1.13 EPS for the current year.
About Enovix
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Further Reading
- Five stocks we like better than Enovix
- What is a Special Dividend?
- MarketBeat Week in Review – 4/22 – 4/26
- How to Choose Top Rated Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
- What is the S&P 500 and How It is Distinct from Other Indexes
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.